Annual Congress Vienna 2003

Saturday, 27.09.2003
Sunday, 28.09.2003
Monday, 29.09.2003
Tuesday, 30.09.2003
Wednesday, 01.10.2003

Citations should be made in the following way: Authors. Title. Eur Respir J 2003; 22: Suppl. 45, abstract number.

Material from 2003:

3196 Abstracts
374 Slide presentations

Material from 2003: Show

Non-steroidal drugs in the treatment of respiratory diseases

Thematic Poster Session
Chairs: G. D'Amato (Naples, Italy), M. Kraft (Denver, United States Of America)

Download all media

The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells E. Agea, A. M. Russano, O. Bistoni, F. Spinozzi, F. M. deBenedictis (Ancona, Italy)
The effect of montelukast on eosinophil apoptosis: Induced sputum findings of patients with mild persistant asthma O. Abadoglu, D. Mungan, O. Aksu, S. Erekul, Z. Misirligil (Ankara, Turkey)
The correlation of BAL cells and clinical-functional parameters in children with stable asthma after antileukotriene therapy D. Vancea, C. Bunu, V. Paunescu (Timisoara, Romania)
*Assessment of in vivo* 5-lipoxygenase (5-LO) activity in nonatopic and atopic subjects with or without asthma: effects of treatment with the 5-LO inhibitor zileuton** F. Gaber, I. Delin, M. Kumlin (Stockholm, Sweden)
Effects of montelukast 10 mg O.D or placebo on blood ROS levels in current smokers: a controlled, randomised, double blind-study R. W. Dal Negro, C. Micheletto, M. Visconti (Bussolengo, Italy)
Cysteinyl leukotrienes and leukotriene B₄ in expired breath condensate in patients with chronic asthma treated with montelukast W. A. Biernacki, H. M. Biernacka, S. A. Kharitonov, P. J. Barnes (London, United Kingdom)
The influence of antileukotriene therapy with montelukast (M) on thromboxane B₂/leukotriene E₄ (TXB₂/LTE₄) ratio in the urine of asthmatic subjects and other inflammatory markers J. Mazurek, J. Wronska, A. Safianowska, H. Grubek-Jaworska, R. Chazan (Warsaw, Poland)
Effects of montelukast vs. placebo on small airways function: assessment using functional HRCT and physiologic measures E. C. Kleerup, M. R. Zeidler, J. G. Goldin, D. A. Truong, D. P. Tashkin (Los Angeles, United States Of America)
Dosage tapering of inhalatory budesonide in subjects with mild-moerate persistent asthma treated with montelukast G. Riccioni, N. D‘Orazio, M. Castronuovo, V. Menna, M. S. Lambo, F. Di Stefano, G. Salvatore, F. Filippakos, R. Della Vecchia (Chieti, Italy)
Comparison of inhibitory potentials of pranlukast and zafirlukast on human liver CYP isoforms Y. M. Lee, M. J. Kim, J. Y. Park, I. J. Cha, J. G. Shin (Pusan, South Korea)
Efficacy of low dose theophylline in patient with bronchial asthma - anti-inflammatory effect G. A. Breskovska, B. G. Gerovski, M. T. Gavrilovski, B. I. Kaeva (Skopje, Macedonia)
*Pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects after a single, oral dose of 500µg roflumilast in the morning versus* evening** B. Hauns, A. Huennemeyer, M. Seiberling, K. Zech, R. Kuelzer, F. Reutter, T. D. Bethke (Konstanz, Germany; Allschwil, Switzerland)
Roflumilast and its active metabolite roflumilast N-oxide do not interact with R- and S-warfarin B. Hauns, A. Huennemeyer, L. Duursema, D. Hauschke, K. Zech, J. Terblanché, L. Venter, T. D. Bethke (Konstanz, Germany; Bloemfontein, Rivonia, South Africa)
The adenosine A_2A-Receptor is not involved in adenosine induced bronchoconstriction in asthmatics B. Luijk, L. Cass, J. W. J. Lammers (Utrecht, The Netherlands; Greenford, United Kingdom)
Effect of oxolamine on cough sensitivity in asthma patients E. Eryuksel, S. Karakurt, B. Ceyhan (Istanbul, Turkey)
Antihistamines (cetirizine and loratadine) and antileukotriene (montelukast) in the prevention of allergic rhinitis symptoms M. Kurowski, P. Kuna, P. Gorski (Lodz, Poland)
Effect of fexofenadine on cough reflex sensitivity and pulmonary function P. V. Dicpinigaitis, Y. E. Gayle (Bronx, United States Of America)
IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma M. W. Morgan, J. C. Cadman, R. I. Ketchell, M. I. Allenby, R. Djukanovic, B. J. O'Connor (London, Southampton, United Kingdom)
New perspectives of basic aspirin-induced asthma therapy H. V. Evsyukova (St Petersburg, Russia)
Vitamin E supplementation in the treatment of asthma: a randomised controlled trial P. J. K. Pearson, A. Fogarty, S. A. Lewis, J. R. Britton (Nottingham, United Kingdom)